CVS to split off drugstore business in major breakup of healthcare giant
The move would reverse the company's $78 billion acquisition of Aetna, and dismantle the vertically integrated healthcare conglomerate it created in 2018.
CVS Health's plan to split off its drugstore business marks a significant reversal of its 2018 acquisition of Aetna, a deal that was touted as a game-changer in the healthcare industry. At the time, the $78 billion acquisition was seen as a bold move to create a vertically integrated healthcare conglomerate, with CVS's retail pharmacies, pharmacy benefits management business, and Aetna's health insurance operations under one roof.
The decision to split off the drugstore business suggests that the company has reevaluated its strategy and is now prioritizing its core health services and benefits business. This move may be seen as a positive development for investors, as it could allow CVS to focus on its more profitable and growth-oriented businesses. However, it also raises questions about the future of the company's retail pharmacy operations and the potential impact on its relationships with suppliers and partners.
Looking ahead, investors will be watching to see how CVS executes on this strategic shift and what implications it has for the company's financial performance and competitive position. Key questions include what the separated drugstore business will look like, how it will be capitalized, and what opportunities or challenges arise from this new structure. Additionally, investors will be monitoring how this move affects CVS's rivals in the healthcare and pharmacy benefits management spaces, and whether it sparks further consolidation or strategic changes in the industry.
Originally reported by cnbc.com. FundNews adds analysis for finance & markets readers.